NDC 70518-2301-1 - Ceftriaxone Sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 70518-2301
Requested NDC: 70518-2301-1
Package NDCs from labels: 70518-2301-1, 70518-2301-0
Manufacturer: REMEDYREPACK INC.
Effective date: 2025-07-01
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Ceftriaxone for Injection, USP Rx Only	REMEDYREPACK INC.	2025-07-01	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70518-2301	CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [REMEDYREPACK INC.]	7	Legacy NDC	20250311_f33a15cb-2ec8-4a5b-84ff-362fe9a67128.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 36 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sportpharm LLC	ddbc3bf6-5bab-4851-ae5a-ef263cd8f255	2026-07-23	Warnings, Adverse reactions	Exact identifier application number: ANDA065169 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone	CEFTRIAXONE	WG Critical Care, LLC	86ec0a92-a552-4a6d-9125-a54f95e43392	2026-06-18	Warnings, Adverse reactions	Exact identifier unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sportpharm LLC	85ce4f8b-77e0-48bf-9f57-93f1478befa2	2026-04-24	Warnings, Adverse reactions	Exact identifier rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sportpharm LLC	9a937e47-8c36-4656-83e1-b3c18ed9bac3	2026-04-24	Warnings, Adverse reactions	Exact identifier rxcui: 1665005 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	REMEDYREPACK INC.	9c801096-ca61-4b29-a1e1-5f7e7813b191	2026-02-06	Warnings, Adverse reactions	Exact identifier application number: ANDA065169 rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Qilu Pharmaceutical Co., Ltd.	4cdf0743-c62b-4969-b9c9-4c6400644f6c	2026-02-04	Warnings, Adverse reactions	Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Hospira, Inc	128bb292-d174-4769-b3e6-9f16617f31e3	2026-01-22	Warnings, Adverse reactions	Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Hospira, Inc	19141ccd-e66c-49a2-a794-0616028495a7	2026-01-19	Warnings, Adverse reactions	Exact identifier application number: ANDA065169 rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Hospira, Inc	03283208-8616-4117-9d2b-aa8046017a4f	2026-01-19	Warnings, Adverse reactions	Exact identifier application number: ANDA065169 rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Hospira, Inc	365fc265-8e6c-432f-9fda-911f5f7fb451	2026-01-16	Warnings, Adverse reactions	Exact identifier unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Hospira, Inc	36c07ebf-b091-483e-b2c4-f0fc0c2b4186	2026-01-16	Warnings, Adverse reactions	Exact identifier unii: 023Z5BR09K
Ceftriaxone	CEFTRIAXONE	WG Critical Care, LLC	7bed9b33-29e3-4f04-9766-43a21c7ad47a	2026-01-07	Warnings, Adverse reactions	Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K
3cf72147-8b99-8444-e063-6294a90ad348			f33a15cb-2ec8-4a5b-84ff-362fe9a67128	2025-08-22	Warnings, Adverse reactions	Exact identifier spl set id: f33a15cb-2ec8-4a5b-84ff-362fe9a67128
Ceftriaxone	CEFTRIAXONE	WG Critical Care, LLC	befd73ff-cb3b-4543-8a8e-bdb9b7fc1ff0	2025-04-07	Warnings, Adverse reactions	Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sandoz Inc	53df951b-2eee-44b1-bae2-df7ed85bc0ed	2025-02-28	Warnings, Adverse reactions	Exact identifier unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sandoz Inc	de028434-46cf-44f6-8ac6-889c7c6943b3	2025-02-27	Warnings, Adverse reactions	Exact identifier application number: ANDA065169 ndc (product): 0781-3207 rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 spl id: 371d8db2-5d67-4339-92b7-aee2a52b2293 spl set id: de028434-46cf-44f6-8ac6-889c7c6943b3 unii: 023Z5BR09K
Ceftriaxone	CEFTRIAXONE SODIUM	Baxter Healthcare Company	4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1	2024-10-07	Warnings, Adverse reactions	Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	A-S Medication Solutions	53415af6-4072-4339-83e2-d870ae02a0e2	2024-08-20	Warnings, Adverse reactions	Exact identifier rxcui: 1665005 unii: 023Z5BR09K
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	A-S Medication Solutions	b642877e-0d36-4218-afe9-0a39f35b571d	2024-03-27	Warnings, Adverse reactions	Exact identifier application number: ANDA065169 rxcui: 1665005 unii: 023Z5BR09K
Ceftriaxone	CEFTRIAXONE	Civica, Inc.	96f3fc1e-84f4-4e9b-91ac-19a1692f227a	2024-02-06	Warnings, Adverse reactions	Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.